BRIEF COMMUNICATION |
|
Year : 2012 | Volume
: 60
| Issue : 4 | Page : 315-317 |
|
Desferrioxamine-related ocular toxicity: A case report
Sumu Simon, Paul A Athanasiov, Rajeev Jain, Grant Raymond, Jagjit S Gilhotra
Retinal Unit, Department of Ophthalmology and Visual Sciences, Royal Adelaide Hospital, South Australia
Correspondence Address:
Sumu Simon Department of Ophthalmology and Visual Sciences, Royal Adelaide Hospital, North Terrace, Adelaide-5000 South Australia
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/0301-4738.98714
|
|
A 29-year-old lady receiving repeated blood transfusions for β thalassemia since childhood, presented with rapidly deteriorating symptoms of night blindness and peripheral visual field loss. She was recently commenced on high-dose intravenous desferrioxamine for reducing the systemic iron overload. Clinical and investigative findings were consistent with desferrioxamine-related pigmentary retinopathy and optic neuropathy. Recovery was partial following cessation of desferrioxamine. This report highlights the ocular side-effects of desferrioxamine mesylate and the need to be vigilant in patients on high doses of desferrioxamine. |
|
|
|
[FULL TEXT] [PDF]* |
|
|
|